Avonex and Cyclophosphamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Avonex (interferon beta 1a) and Cyclophosphamide (cyclophosphamide). Common drug interactions include craniocerebral injury among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Avonex and Cyclophosphamide. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Avonex?

Avonex has active ingredients of interferon beta 1a. It is often used in multiple sclerosis. eHealthMe is studying from 198,544 Avonex users. Check the latest studies of Avonex.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.



On Jul, 14, 2026

43 people who take Avonex and Cyclophosphamide together, and have interactions are studied.

Avonex and Cyclophosphamide drug interactions.

What are the common drug interactions of Avonex and Cyclophosphamide, by gender? *:

female:

  1. Craniocerebral injury (injury to cranium and brain)
  2. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  3. Epistaxis (bleed from the nose)
  4. Hepatic steatosis (fatty liver disease)
  5. Hip fracture
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  7. Hysterectomy
  8. Intestinal obstruction
  9. Microangiopathy (disease of the capillaries (very small blood vessels), in which the capillary walls become so thick and weak that they bleed, leak protein)
  10. Post procedural haematoma (post procedural clotting of blood)

male:

  1. Pneumonia
  2. Back pain
  3. Syncope (loss of consciousness with an inability to maintain postural tone)
  4. Blindness
  5. Malignant melanoma (skin cancer rises from melancytes)
  6. Neoplasm malignant (cancer tumour)
  7. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  8. Optic atrophy (the loss of a proportion of optic disc nerve fibres)
  9. Influenza like illness
  10. Abdominal pain upper

What are the common drug interactions of Avonex and Cyclophosphamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Hiv infection
  2. Influenza like illness
  3. Syncope (loss of consciousness with an inability to maintain postural tone)
  4. Completed suicide (act of taking one's own life)
  5. Suicidal ideation
  6. Suicide attempt

20-29:

  1. Asthenia (weakness)
  2. Balance disorder
  3. Blood follicle stimulating hormone increased
  4. Blood luteinising hormone increased
  5. Drug ineffective
  6. Fall
  7. Fatigue (feeling of tiredness)
  8. Influenza like illness
  9. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
  10. Muscular weakness (muscle weakness)

30-39:

  1. Fatigue (feeling of tiredness)
  2. Asthenia (weakness)
  3. Balance disorder
  4. Fall
  5. Influenza like illness
  6. Injection site bruising
  7. Injection site discolouration
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Weight increased
  10. White blood cell count decreased

40-49:

  1. Constipation
  2. Depressed level of consciousness
  3. Drug hypersensitivity
  4. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Haemangioma of liver (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in liver)
  7. Headache (pain in head)
  8. Hyperhidrosis (abnormally increased sweating)
  9. Malignant fibrous histiocytoma (a cancer tumour of uncertain origin that arises both in soft tissue and bone)
  10. Nasopharyngitis (inflammation of the nasopharynx)

50-59:

  1. Pneumonia
  2. Myelosuppression (a decrease in the production of blood cells)
  3. Back pain
  4. Fatigue (feeling of tiredness)
  5. Dysstasia (difficulty in standing)
  6. Vomiting
  7. Diarrhoea
  8. Headache (pain in head)
  9. Nausea (feeling of having an urge to vomit)
  10. Breast cancer female

60+:

  1. Breast cancer
  2. Axillary vein thrombosis (formation of a blood clot in axillary vein)
  3. Aphasia (damage to the parts of the brain that control language)
  4. Arthralgia (joint pain)
  5. Back pain
  6. Chills (felling of cold)
  7. Coma (state of unconsciousness lasting more than six hours)
  8. Depressed mood
  9. Dyspnoea (difficult or laboured respiration)
  10. Faecal occult blood (blood clot in stool)

What are the existing conditions these people have? *

  1. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 11.63%

* Approximation only. Some reports may have incomplete information.

Do you take Avonex and Cyclophosphamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Avonex and Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Avonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Avonex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cyclophosphamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on interferon beta 1a and cyclophosphamide (the active ingredients of Avonex and Cyclophosphamide, respectively), and Avonex and Cyclophosphamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: